Drugs / Anti-oxLDL IgM antibody
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02707211 | Jun 2016 → Feb 2017 | lysosomal lipid storage disorder | Universitaire Ziekenhuizen KU Leuven | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-oxLDL IgM antibody | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02707211 ↗ |
| Modality | Protein / enzyme biologic | “Anti-oxLDL IgM antibody” NCT02707211 ↗ |